These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25976011)

  • 1. Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.
    Mehrotra A; Kanwal A; Banerjee SK; Sandhir R
    Neurobiol Aging; 2015 Jun; 36(6):2186-200. PubMed ID: 25976011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial modulators improve lipid composition and attenuate memory deficits in experimental model of Huntington's disease.
    Mehrotra A; Sood A; Sandhir R
    Mol Cell Biochem; 2015 Dec; 410(1-2):281-92. PubMed ID: 26374445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial cofactors in experimental Huntington's disease: behavioral, biochemical and histological evaluation.
    Mehrotra A; Sandhir R
    Behav Brain Res; 2014 Mar; 261():345-55. PubMed ID: 24393741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
    Sandhir R; Sood A; Mehrotra A; Kamboj SS
    Neurodegener Dis; 2012; 9(3):145-57. PubMed ID: 22327485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S; Ramachandran S; Krishnamurthy P
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease.
    Sandhir R; Mehrotra A
    Biochim Biophys Acta; 2013 Mar; 1832(3):421-30. PubMed ID: 23220257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
    Hariharan A; Shetty S; Shirole T; Jagtap AG
    Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.
    Sandhir R; Mehrotra A; Kamboj SS
    Neurochem Int; 2010 Nov; 57(5):579-87. PubMed ID: 20643176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of phosphodiesterase-1 (PDE1) and ATP sensitive potassium (KATP) channel modulators against 3-nitropropionic acid induced behavioral and biochemical toxicities in experimental Huntington׳s disease.
    Gupta S; Sharma B
    Eur J Pharmacol; 2014 Jun; 732():111-22. PubMed ID: 24690258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
    Kumar P; Kumar A
    J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P; Kumar A
    Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
    Binawade Y; Jagtap A
    J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
    Gupta S; Sharma B
    Brain Res Bull; 2014 Mar; 102():57-68. PubMed ID: 24582883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease.
    Sandhir R; Mahajan N; Mehrotra A; Aggarwal A; Sunkaria A
    Synapse; 2015 Mar; 69(3):128-38. PubMed ID: 25482019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
    Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
    Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
    Kumar P; Kalonia H; Kumar A
    Behav Pharmacol; 2010 May; 21(3):217-30. PubMed ID: 20480544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyl-L-carnitine and alpha-lipoic acid: possible neurotherapeutic agents for mood disorders?
    Soczynska JK; Kennedy SH; Chow CS; Woldeyohannes HO; Konarski JZ; McIntyre RS
    Expert Opin Investig Drugs; 2008 Jun; 17(6):827-43. PubMed ID: 18491985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease.
    Sandhir R; Yadav A; Mehrotra A; Sunkaria A; Singh A; Sharma S
    Neuromolecular Med; 2014 Mar; 16(1):106-18. PubMed ID: 24008671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.